CUAMC
PTCT icon

China Universal Asset Management Company’s PTC Therapeutics PTCT Stock Holding History

China Universal Asset Management Company’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
13,201
-1,488
-10% -$107K 0.06% 196
2026
Q1 		$1M Buy
14,689
+1,506
+11% +$107K 0.08% 190
2025
Q4 		$1M Sell
13,183
-741
-5% -$53.9K 0.08% 188
2025
Q3 		$855K Sell
13,924
-1,994
-13% -$104K 0.07% 192
2025
Q2 		$777K Buy
15,918
+98
+0.6% +$4.65K 0.07% 198
2025
Q1 		$806K Sell
15,820
-533
-3% -$26.6K 0.08% 207
2024
Q4 		$738K Buy
16,353
+1,558
+11% +$66.7K 0.07% 200
2024
Q3 		$549K Buy
14,795
+5,783
+64% +$194K 0.06% 203
2024
Q2 		$276K Sell
9,012
-5,740
-39% -$186K 0.04% 200
2024
Q1 		$429K Buy
14,752
+6,025
+69% +$169K 0.05% 198
2023
Q4 		$241K Buy
8,727
+6,786
+350% +$155K 0.05% 190
2023
Q3 		$43.5K Buy
1,941
+969
+100% +$36K 0.01% 236
2023
Q2 		$39.5K Sell
972
-28
-3% -$1.37K 0.01% 215
2023
Q1 		$48.4K Buy
1,000
+269
+37% +$12.3K 0.02% 152
2022
Q4 		$27.9K Buy
731
+61
+9% +$2.54K 0.01% 157
2022
Q3 		$34K Buy
+670
New +$32.8K 0.01% 136

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

China Universal Asset Management Company's PTCT Position: Q2 2026 in Review

China Universal Asset Management Company reduced its PTC Therapeutics (PTCT) stake by 10% in Q2 2026, selling an estimated $107K and leaving 13,201 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #196.

China Universal Asset Management Company first reported a position in PTCT in Q3 2022 and has held it in 16 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • China Universal Asset Management Company held 13,201 shares of PTC Therapeutics worth $1.08M as of Q2 2026.
  • China Universal Asset Management Company sold 1,488 PTC Therapeutics shares in Q2 2026, an estimated $107K.
  • PTC Therapeutics made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #196 holding.
  • China Universal Asset Management Company first reported a position in PTC Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.